|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||106.95 - 110.98|
|52 Week Range||71.30 - 113.88|
|PE Ratio (TTM)||22.97|
|Earnings Date||Jul 24, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||124.88|
Moody's Investors Service has upgraded Centene Corporation's (Centene: NYSE: CNC) senior debt rating to Ba1 from Ba2 in recognition of its continued strong profitability and vastly improved business profile, ...
The end of the individual mandate that requires Americans to buy health insurance coverage or face a penalty might not be so bad after all if you hear a former Obama administration official turned health insurance executive tell it. His comments were made during Centene’s first quarter earnings call Tuesday in response to analysts’ question about the insurer’s future enrollment when the mandate to buy coverage goes away next year. told Wall Street analysts about his days at the Centers for Medicare & Medicaid Services working as the first CEO of Health Insurance Marketplaces.
Centene has been forced to lower its 2018 forecast because of an acquisition delay and extra costs.
Michael Neidorff, chairman and chief executive officer of Centene Corp., left, and Bernard Tyson, chief executive officer of Kaiser Permanente, right, wait to go through security near the White House in Washington, D.C., U.S., on Wednesday, Oct. 23, 2013. Health insurer Centene said first-quarter profits and revenue surged as the company successfully manages costs of its larger enrollment in individual health plans under the Affordable Care Act.
NEW YORK, NY / ACCESSWIRE / April 24, 2018 / Centene Corporation (NYSE: CNC ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 24, 2018 at 8:30 AM Eastern Time. To ...
Centene Corp on Tuesday reported a quarterly profit that more than doubled, as it added more members to its health insurance plans, including its Obamacare business, as well as lower costs in its Medicaid unit. Centene, which primarily focuses on government-sponsored health plans, said net earnings rose to $338 million, or $1.91 per share, in the first quarter ended March 31 from $132 million, or 79 cents per share, a year earlier. The ratio is a closely watched measure by investors for increased medical costs and usage.
On a per-share basis, the St. Louis-based company said it had profit of $1.91. Earnings, adjusted for one-time gains and costs, came to $2.17 per share. The results surpassed Wall Street expectations. ...
Centene Corp on Tuesday reported a quarterly profit that more than doubled as it added more members to its health insurance plans. Centene, which primarily focuses on government-sponsored health plans, ...
-- 2018 First Quarter Diluted EPS of $1.91 ; Adjusted Diluted EPS of $2.17 -- ST. LOUIS , April 24, 2018 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the first ...
Centene Corporation (NYSE:CNC) delivered a less impressive 11.75% ROE over the past year, compared to the 13.29% return generated by its industry. CNC’s results could indicate a relatively inefficient operationRead More...
As previously announced, on September 12, 2017, Centene Corporation and Fidelis Care entered into an Asset Purchase Agreement pursuant to which, among other things, a newly formed, wholly owned subsidiary of Centene will purchase substantially all of the assets of Fidelis Care for approximately $3.75 billion. "We are pleased to have crossed these milestones and look forward to working with the regulatory authorities and Attorney General through the completion of the process," said Michael F. Neidorff, Chairman and CEO of Centene Corporation.
Centene's (CNC) first quarter 2018 results are likely to benefit from Medicaid expansion as well as rising participation in exchanges.
The agreement enables funding to support the Catholic Health Foundation, and does it all while protecting state taxpayers.
NEW YORK, NY / ACCESSWIRE / April 17, 2018 / U.S. markets surged Monday as fears of conflict in Syria eased and earnings season kicked off with a strong start. The Dow Jones Industrial Average spiked 0.87 ...
We are optimistic about Haemonetics' (HAE) improved Plasma franchise as strong end-market demand for plasma-derived biopharmaceuticals consistently drives growth for the company.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting CNC. Over the last one-month, outflows of investor capital in ETFs holding CNC totaled $16.62 billion.
GNC Holdings' (GNC) tie-up with Rapid Nutrition is likely to fuel the company's entry and expansion into the Australian healthcare market.
Zimmer Biomet's (ZBH) dull Knee sales continue to bother due to slower pace of supply recovery and sales recapture of certain key brands.